Genetic evaluation of 50 Turkish patients with neurofibromatosis type 1: 2 years experience of a single center
- PMID: 37280783
- DOI: 10.1002/jdn.10278
Genetic evaluation of 50 Turkish patients with neurofibromatosis type 1: 2 years experience of a single center
Abstract
Background/aim: Neurofibromatosis type 1 is an autosomal dominant neurocutaneous disorder. Clinical diagnosis is difficult in early childhood, and it is possible to miss a critical interval for tumour screening. In this study, we aimed to characterize the mutational spectrum of Turkish patients and discuss the benefits of molecular testing.
Material and methods: Fifty individuals from 35 unrelated families were included. Main referral reasons for genetic testing were as follows: to confirm a clinical diagnosis, to use in differential diagnosis and to evaluate first-degree family member of a known patient. Two-step process consisting of initial next generation sequencing of the NF1 gene and consequent multiplex ligation-dependent probe amplification were performed.
Results: We identified a total of 30 variants in 28 individuals. Variant detection rate was 56% in the entire study group and 71.4% within the index patients. Four novel variants were found. Truncating variants constituted 60% of the entire mutation spectrum. A deletion or duplication was not detected. The most common feature was cafe au lait macules in 70% of the patients, followed by focal areas of signal intensity on brain imaging (26%), cutaneous neurofibromas (24%) and axillary freckling (24%).
Conclusions: Early sequencing in all suspected patients followed by deletion/duplication analysis in patients meeting clinical criteria and a case-to-case based consideration for RNA studies seems to be the effective algorithm for NF-1 diagnosis.
Keywords: NF1; cafe au lait macules; early diagnosis; genotype-phenotype correlation; neurofibromatosis type 1.
© 2023 International Society for Developmental Neuroscience.
References
REFERENCES
-
- Anastasaki, C., Gao, F., & Gutmann, D. H. (2019). Commentary: Identification of mutation regions on NF1 responsible for high- and low-risk development of optic pathway glioma in Neurofibromatosis type I. Frontiers in Genetics, 10, 115. https://doi.org/10.3389/fgene.2019.00115
-
- Bettegowda, C., Upadhayaya, M., Evans, D. G., Kim, A. R., Mathios, D., Hanemann, C. O., & on behalf of the REiNS International Collaboration. (2021). Genotype-phenotype correlations in Neurofibromatosis and their potential clinical use. Neurology, 97(7 Suppl 1), S91-S98. https://doi.org/10.1212/WNL.0000000000012436
-
- Castellanos, E., Rosas, I., Negro, A., Gel, B., Alibés, A., Baena, N., Pineda, M., Pi, G., Pintos, G., Salvador, H., Lázaro, C., Blanco, I., Vilageliu, L., Brems, H., Grinberg, D., Legius, E., & Serra, E. (2020). Mutational spectrum by phenotype: Panel-based NGS testing of patients with clinical suspicion of RASopathy and children with multiple café-au-lait macules. Clinical Genetics, 97(2), 264-275. https://doi.org/10.1111/cge.13649
-
- ClinVar database NF1 (n.d.). Available at: https://www.ncbi.nlm.nih.gov/clinvar/?term=NF1[sym] (Accessed: 5 March 2022).
-
- Ece Solmaz, A., Isik, E., Atik, T., Ozkinay, F., & Onay, H. (2021). Mutation spectrum of the NF1 gene and genotype-phenotype correlations in Turkish patients: Seventeen novel pathogenic variants. Clinical Neurology and Neurosurgery, 208, 106884. https://doi.org/10.1016/j.clineuro.2021.106884
MeSH terms
Supplementary concepts
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous